Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis Journal
Published
2025-12-26
DOI
https://doi.org/10.1177/13524585251396433
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial

Martin Belkin, Nathalie Franchimont, Maria L. Naylor, H. Hartung et al.
1 citations
Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
1.47
article

Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial

Martin Belkin, Nathalie Franchimont, Maria L. Naylor, H. Hartung, Andrija Javor, Ian Tagge, Shibeshih Mitiku Belachew, Daniel P. Bradley, SD Newsome, Bing Zhu, Katherine Riester, Peter A. Calabresi, Maria Pia Sormani, E Bartholomé, Douglas Lorne Arnold, Robert T. Naismith, Jennifer Lyons, Aaron Deykin, Wenjie Cheng, Elizabeth Fisher, R M Fox, Martin Valis, Ludwig Kappos, Gavin Giovannoni
article en
1 citations

Abstract

No abstract available for this paper.
Multiple Sclerosis JournalVol. 32(1)
Montreal Neurological Institute and Hospital (CA), Biogen (United States) (US), Cleveland Clinic (US), Queen Mary University of London (GB), Washington University in St. Louis (US), Charles University (CZ), University Hospital of Basel (CH), Hospital Base (CL), Michigan Institute for Neurological Disorders (US), NeuroRx Research (Canada) (CA), Johns Hopkins Hospital (US), Heinrich Heine University Düsseldorf (DE), McGill University (CA), Palacký University Olomouc (CZ), University of Genoa (IT)
Good health and well-being
Openalex Percentile: Top 13%
Multiple Sclerosis Research Studies
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.